Cargando…
Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation
BACKGROUND AND AIM: This study evaluates whether a stool donor program to supply fecal microbiota transplantation (FMT) product is feasible in the Australian regulatory environment. The primary outcome was capacity to supply FMT product. The secondary outcomes were donor eligibility, retention, and...
Autores principales: | Tucker, Emily C, Haylock‐Jacobs, Sarah, Rapaic, Mirjana, Dann, Lisa M, Bryant, Robert V, Costello, Samuel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037028/ https://www.ncbi.nlm.nih.gov/pubmed/36968571 http://dx.doi.org/10.1002/jgh3.12874 |
Ejemplares similares
-
Challenges and costs of donor screening for fecal microbiota transplantations
por: Bénard, Mèlanie V., et al.
Publicado: (2022) -
A comprehensive approach to stool donor screening for faecal microbiota transplantation in China
por: He, Jianquan, et al.
Publicado: (2021) -
Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020) -
Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021) -
Laboratory Aspects of Donor Screening for Fecal Microbiota Transplantation at a Korean Fecal Microbiota Bank
por: Seo, Hyun Soo, et al.
Publicado: (2021)